Buscar

Comenzar nueva busqueda
Añadir filtros:

Usa los filtros para afinar la busqueda.


Resultados 351-360 de 5166.
Resultados por ítem:
Vista previaFecha de publicaciónTítuloAutor(es)Acceso
Endocrine disruption in Crohn’s disease Bisphenol A enhances.pdf.jpg2021Endocrine disruption in Crohn’s disease: Bisphenol A enhances systemic inflammatory response in patients with gut barrier translocation of dysbiotic microbiota products
Linares, Raquel; Fernández, Mariana F.; Gutiérrez, Ana; García-Villalba, Rocío; Suárez, Beatriz; Martínez-Blázquez, José Alberto; Caparrós, Esther; Tomás-Barberán, Francisco A.; Francés, Rubén
Subclinical atherosclerosis in low Framingham risk HIV patients.pdf.jpgago-2017Subclinical atherosclerosis in low Framingham risk HIV patients
León, Rafael; Reus Bañuls, Sergio Javier; López, Nicolás; Portilla, Irene; Sánchez Payá, José; Giner, Livia; Boix Martínez, Vicente; Merino de Lucas, Esperanza; Torrús Tendero, Diego; Moreno Pérez, Óscar; Portilla Sogorb, Joaquín
Procalcitonin and C-reactive protein as early markers of anastomotic.pdf.jpgmar-2018Procalcitonin and C-reactive protein as early markers of anastomotic leak after laparoscopic colorectal surgery within an enhanced recovery after surgery (ERAS) program
Muñoz, José Luis; Oliva Alvarez, María; Cuquerella, Vicent; Miranda, Elena; Picó, Carlos; Flores, Raquel; Resalt‑Pereira, Marta; Moya, Pedro; Pérez, Ana; Arroyo, Antonio
236-Texto del artículo-1070-2-10-20181023 (1).pdf.jpgjul-2018Imagen, cuerpo y comunicación en los partidos políticos españolesMartínez Guirao, Javier Eloy; Téllez Infantes, Anastasia; Ramos Lahiguera, Carlos Manuel
Efficacy and safety of insulin glargine 300 UmL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2.pdf.jpg18-jul-2020Efficacy and safety of insulin glargine 300 U/mL (Gla-300) during hospitalization and therapy intensification at discharge in patients with insufficiently controlled type 2 diabetes: results of the phase IV COBALTA trial
Perez, Antonio; Carrasco-Sánchez, Francisco Javier; González, Carlos; Seguí-Ripoll, José Miguel; Trescolí, Carlos; Ena, Javier; Borrell, Mireia; Gomez Huelgas, Ricardo
Dysbiotic microbiota interactions in Crohn’s.pdf.jpg2021Dysbiotic microbiota interactions in Crohn’s disease
Caparrós, Esther; Wiest, Reiner; Scharl, Michael; Rogler, Gerhard; Gutiérrez Casbas, Ana; Yilmaz, Bahtiyar; Wawrzyniak, Marcin; Francés, Rubén
7 - Guil et al. 2017 wildfires and electrocutions.pdf.jpg29-dic-2017Wildfires as collateral effects of wildlife electrocution: An economic approach to the situation in Spain in recent years
Guil, Francisco; Soria, Mari Ángeles; Margalida, Antoni; Pérez-García, Juan Manuel
Gli2-Mediated Shh Signaling Is Required for Thalamocortical Projection Guidance.pdf.jpgfeb-2022Gli2-Mediated Shh Signaling Is Required for Thalamocortical Projection Guidance
Callejas Marín, Antuca; Moreno Bravo, Juan Antonio; Company Devesa, Verónica; Madrigal Verdú, María del Pilar; Almagro García, Francisca de Paula; Martínez Pérez, Salvador; de Puelles Martínez de La Torre, Eduardo
A methodology for the extrapolation.pdf.jpg2019A methodology for the extrapolation of coast-by noise of tyres from sound power level measurements
Campello Vicente, Héctor; Campillo Davo, Nuria; Peral Orts, Ramón; Velasco Sánchez, Emilio
La obesidad es una enfermedad crónica..pdf.jpg26-jul-2020La obesidad es una enfermedad crónica. Posicionamiento del grupo de trabajo de Diabetes, Obesidad y Nutrición de la Sociedad Española de Medicina Interna (SEMI) por un abordaje centrado en la persona con obesidad
Carretero Gómez, J.; Ena, J.; Arévalo-Lorido, José Carlos; Seguí-Ripoll, José Miguel; Carrasco-Sánchez, Francisco Javier; Gómez-Huelgas, R.; Pérez Soto, M.I.; Delgado Lista, J.; Pérez Martínez, P.